Profilo
Robert Paproski is associated with Nanostics, Inc. as the Chief Technology Officer since 2017.
He is the founder of Nanostics, Inc. which was founded in 2017.
Posizioni attive di Robert Paproski
| Società | Posizione | Inizio |
|---|---|---|
Nanostics, Inc.
 Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Fondatore | 01/01/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Health Technology |
- Borsa valori
- Insiders
- Robert Paproski
